Fundraising Fox
Profound Medical
NASDAQ: PROFMississauga · Founded 2015 · 182 employees on LinkedIn · 3 known investors
Find your way into Profound Medical
Sign up to see every warm intro you have to Profound Medical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Profound Medical team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Profound Medical develops real-time MRI-guided thermal ultrasound systems for incision-free ablation of abnormal or cancerous tissue. The company's TULSA-PRO therapeutic system enables precise ablation of diseased prostate tissue in a commercial-stage medical technology setting.
Founders & leadership
AM
Arun MenawatCEOArun Menawat is CEO and Chairman of Profound Medical, a medical technology company developing MRI-guided thermal ultrasound systems for tissue ablation. He previously served as Chairman and CEO of Novadaq Technologies for 13 years, President of Cedara Software, and held executive roles at Tenneco and Hercules; he holds a Ph.D. in Chemical Engineering from the University of Maryland and an Executive MBA from Northwestern University's Kellogg School of Management.
RD
TT
Tom TamberrinoChief Commercial Officer
Board
Investors · 3
CTI Life Sciences Fund L.P.listed by CTI Life Sciences Fund L.P.Montréal
How we know: CTI Life Sciences Fund L.P.'s portfolio page · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$877.5K disclosed across 1 round · 2017
▶$877.5KraisedOct 2017 · 16 investors · BiotechnologyRule 506(b)
▶$877.5KraisedOct 2017 · 16 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jean-Francois PariseauDirector
- Damian LambDirector
- Arun MenawatExecutive Officer, Director
- William CurranDirector
- Samira SakhiaDirector
- Kenneth GalbraithDirector
- Rashed DewanExecutive Officer
- Offering amount
- $877.5K
- Amount sold
- $877.5K
- Sales commissions
- $52.6K
- Placement agents
- CIBC World Markets Corp.
- First sale
- Sep 2017
- Incorporated
- Corporation, Ontario, Canada, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Profound Medical do?
- Profound Medical develops real-time MRI-guided thermal ultrasound systems for incision-free ablation of abnormal or cancerous tissue. The company's TULSA-PRO therapeutic system enables precise ablation of diseased prostate tissue in a commercial-stage medical technology setting.
- Who are Profound Medical's investors?
- Profound Medical's investors include CTI Life Sciences Fund L.P., FACIT (Fight Against Cancer Innovation Trust), Genesys Capital.
- How much funding has Profound Medical raised?
- Profound Medical has disclosed $877.5K raised across 1 round.
- Where is Profound Medical headquartered?
- Profound Medical is headquartered in Mississauga.